Latest Expert Opinions

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
January 8, 2019
(A Top Pick Jan 11/18, Up 8%) Likes it. There are really two robust parts of the healtcare sector, one is this one, medical devices and equipment, and the other is managed care. You are buying market beta here; if the market goes down, IHI is going down. They might be high quality and good cash flow, but don't think of this as safety. Loves it and would stick with it.
Show full opinionHide full opinion
(A Top Pick Jan 11/18, Up 8%) Likes it. There are really two robust parts of the healtcare sector, one is this one, medical devices and equipment, and the other is managed care. You are buying market beta here; if the market goes down, IHI is going down. They might be high quality and good cash flow, but don't think of this as safety. Loves it and would stick with it.
PAST TOP PICK
PAST TOP PICK
January 8, 2019
(A Top Pick Jan 11/18, Down 14%) Sold last summer. Nothing wrong with the company. Still loves it fundamentally but poorly timed.
Show full opinionHide full opinion
(A Top Pick Jan 11/18, Down 14%) Sold last summer. Nothing wrong with the company. Still loves it fundamentally but poorly timed.
PAST TOP PICK
PAST TOP PICK
January 8, 2019
(A Top Pick Jan 11/18, Down 38%) Probably one of his worst pick to date. The stock got pummeled after they highlighted that the macro uncertainty and trade tension with China was problematic. Sold it.
Show full opinionHide full opinion
FedEx (FDX-N)
January 8, 2019
(A Top Pick Jan 11/18, Down 38%) Probably one of his worst pick to date. The stock got pummeled after they highlighted that the macro uncertainty and trade tension with China was problematic. Sold it.
DON'T BUY
DON'T BUY
January 8, 2019
Two sides to it. Pharmacy benefit side (PBM) and the retail side. Doesn't like the pharmacy benefit side. Generics pricing is an headwind. They are doing a number of right things but there is nothing to get really excited about. Prefers UNH-N.
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
January 8, 2019
Two sides to it. Pharmacy benefit side (PBM) and the retail side. Doesn't like the pharmacy benefit side. Generics pricing is an headwind. They are doing a number of right things but there is nothing to get really excited about. Prefers UNH-N.
WAIT
WAIT
January 8, 2019
Price to book ratio play. Classically you buy it below book and sell it at 1.5-1.8X. Currently 0.86X price to book looks really tempting. They are not as susceptible to net interest margin, to the credit, to a number of factors that are going to hit banks. Much more focused business line, great wealth management, great asset management, great trading capital market and investment banking. But at the end of the day we are at the end of the cycle and now may not be the time to buy this.
Show full opinionHide full opinion
Goldman Sachs (GS-N)
January 8, 2019
Price to book ratio play. Classically you buy it below book and sell it at 1.5-1.8X. Currently 0.86X price to book looks really tempting. They are not as susceptible to net interest margin, to the credit, to a number of factors that are going to hit banks. Much more focused business line, great wealth management, great asset management, great trading capital market and investment banking. But at the end of the day we are at the end of the cycle and now may not be the time to buy this.
DON'T BUY
DON'T BUY
January 8, 2019
Home building, flooring, both residential and commercial. Was trading at $250 less than year ago, now is trading at $123. Revenues might be positivem but still in restructuring, and negative EPS for next year. Would stay away. This is the kind of chart they stay a million miles away from.
Show full opinionHide full opinion
Home building, flooring, both residential and commercial. Was trading at $250 less than year ago, now is trading at $123. Revenues might be positivem but still in restructuring, and negative EPS for next year. Would stay away. This is the kind of chart they stay a million miles away from.
COMMENT
COMMENT
January 8, 2019
Percentage of cash in your U.S. equity portfolio? They are 15% cash right now, about 40% bounds and 45% equities. Doesn't love the market right now.
Show full opinionHide full opinion
CASH (CASH)
January 8, 2019
Percentage of cash in your U.S. equity portfolio? They are 15% cash right now, about 40% bounds and 45% equities. Doesn't love the market right now.